Assenagon Asset Management S.A. Purchases 26,235 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE)
Assenagon Asset Management S.A. raised its position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 12.4% during the 4th quarter, HoldingsChannel reports. The fund owned 238,522 shares of ...
Xenon Pharmaceuticals announces executive changes
Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a $3 billion market cap pharmaceutical company specializing in the development of therapeutic drugs, announced today the departure of its Chief Commercial ...
Mountain climbing and treating Alzheimer's: Could xenon gas have potential?
In a trial featuring a mouse model of Alzheimer's, scientists found that inhaling a mixture containing xenon gas helped ...
LBC7d
Brit to attempt 'fastest ever' Everest climb, with help from xenon gas
A former British army officer is attempting the 'fastest ever' Everest mission, with help from xenon gas. Everest could be ...
Morningstar10d
Xenon Outlines Key Corporate Milestone Opportunities for 2025
Xenon’s Phase 3 epilepsy program includes three Phase 3 clinical trials in focal onset seizures (FOS) and primary generalized tonic-clonic seizures (PGTCS). Designed closely after the Phase 2b X ...